Amyloid precursor protein (APP) processing

Class

Amyloid-beta production inhibitor (APP processing)

Amyloid precursor protein (APP) is a membrane protein expressed broadly in neurons and other cell types. Its normal function is not fully defined, but it is thought to contribute to synapse formation and cell signaling. APP is cut by a series of enzymes called secretases, and the specific sequence of cuts determines what fragments are produced. One pathway, involving beta-secretase followed by gamma-secretase, releases a small peptide called amyloid-beta. Under certain conditions, amyloid-beta accumulates and aggregates into plaques in brain tissue, a hallmark feature of Alzheimer's disease. An alternative cutting pathway, using alpha-secretase, cleaves APP within the amyloid-beta sequence itself, preventing formation of the aggregation-prone peptide. Therapeutic strategies aimed at APP processing seek to shift this balance: reducing amyloid-beta generation, promoting its clearance, or otherwise altering the ratio of cleavage products. This mechanism class is of interest broadly in neurodegenerative disease research, particularly Alzheimer's disease and related dementias where amyloid accumulation is implicated in disease progression, though the precise causal role of amyloid pathology relative to other processes, such as tau aggregation and neuroinflammation, remains an active area of scientific investigation.